Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Operating Expenses: 2018-2023

Historic Other Operating Expenses for Gossamer Bio (GOSS) over the last 6 years, with Dec 2023 value amounting to $10.0 million.

  • Gossamer Bio's Other Operating Expenses was N/A to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2023, which is 15284.62% up from last year.
  • According to the latest figures from FY2023, Gossamer Bio's Other Operating Expenses is $10.0 million, which was up 15,284.62% from $65,000 recorded in FY2022.
  • In the past 5 years, Gossamer Bio's Other Operating Expenses registered a high of $23.4 million during FY2020, and its lowest value of $65,000 during FY2022.
  • For the 3-year period, Gossamer Bio's Other Operating Expenses averaged around $3.4 million, with its median value being $75,000 (2021).
  • In the last 5 years, Gossamer Bio's Other Operating Expenses tumbled by 99.68% in 2021 and then spiked by 15,284.62% in 2023.
  • Yearly analysis of 5 years shows Gossamer Bio's Other Operating Expenses stood at $3.6 million in 2019, then soared by 549.44% to $23.4 million in 2020, then crashed by 99.68% to $75,000 in 2021, then fell by 13.33% to $65,000 in 2022, then spiked by 15,284.62% to $10.0 million in 2023.